International trade · 08/04/2025Updated: 10/16/2026 · 1 min read
U.S. International Trade Commission Seeks Comments on Drug Product Complaint
Summary
The U.S. International Trade Commission has received a complaint about certain drug products containing C-Type Natriuretic Peptide Variants and is seeking public comments on the issue.
Original source language: Federal Register — International Trade CommissionOpen original release →